These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 8708018)

  • 1. The prevalence of hidradenitis suppurativa and its potential precursor lesions.
    Jemec GB; Heidenheim M; Nielsen NH
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):191-4. PubMed ID: 8708018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of hidradenitis suppurativa in Denmark].
    Jemec GB; Heidenheim M; Nielsen NH
    Ugeskr Laeger; 1998 Feb; 160(6):847-9. PubMed ID: 9469984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa--characteristics and consequences.
    Jemec GB; Heidenheim M; Nielsen NH
    Clin Exp Dermatol; 1996 Nov; 21(6):419-23. PubMed ID: 9167336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.
    Kirsten N; Zander N; Augustin M
    Arch Dermatol Res; 2021 Mar; 313(2):95-99. PubMed ID: 32322958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis.
    Bui TL; Silva-Hirschberg C; Torres J; Armstrong AW
    J Am Acad Dermatol; 2018 Feb; 78(2):395-402. PubMed ID: 29056237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.
    Revuz JE; Canoui-Poitrine F; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Roujeau JC; Bonnelye G; Grob JJ; Bastuji-Garin S
    J Am Acad Dermatol; 2008 Oct; 59(4):596-601. PubMed ID: 18674845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa.
    Vinding GR; Miller IM; Zarchi K; Ibler KS; Ellervik C; Jemec GB
    Br J Dermatol; 2014 Apr; 170(4):884-9. PubMed ID: 24329520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina.
    Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking as a triggering factor of hidradenitis suppurativa.
    König A; Lehmann C; Rompel R; Happle R
    Dermatology; 1999; 198(3):261-4. PubMed ID: 10393449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of hidradenitis suppurativa in an STD population.
    Jemec GB; Heidenheim M; Nielsen NH
    Acta Derm Venereol; 1996 Nov; 76(6):482-3. PubMed ID: 8982418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.
    Schrader AM; Deckers IE; van der Zee HH; Boer J; Prens EP
    J Am Acad Dermatol; 2014 Sep; 71(3):460-7. PubMed ID: 24880664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Garg A; Papagermanos V; Midura M; Strunk A; Merson J
    J Am Acad Dermatol; 2018 Sep; 79(3):495-500.e1. PubMed ID: 29499293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
    Garg A; Birabaharan M; Strunk A
    J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of body weight on the prevalence and severity of hidradenitis suppurativa.
    Kromann CB; Ibler KS; Kristiansen VB; Jemec GB
    Acta Derm Venereol; 2014 Sep; 94(5):553-7. PubMed ID: 24577555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Tannenbaum R; Strunk A; Garg A
    J Am Acad Dermatol; 2019 Jun; 80(6):1533-1537. PubMed ID: 30738122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Characteristics of Hidradenitis Suppurativa in the Northern Finland Birth Cohort 1986 Study: A Cross-sectional Study of 2,775 Subjects.
    Sinikumpu SP; Jokelainen J; Huilaja L
    Acta Derm Venereol; 2024 Jan; 104():adv14732. PubMed ID: 38197699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Epidemiology and Management of Hidradenitis Suppurativa.
    Sayed CJ; Hsiao JL; Okun MM;
    Obstet Gynecol; 2021 Apr; 137(4):731-746. PubMed ID: 33706337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States.
    Garg A; Kirby JS; Lavian J; Lin G; Strunk A
    JAMA Dermatol; 2017 Aug; 153(8):760-764. PubMed ID: 28492923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.